India: Anti-COVID-19 oral drug developed by DRDO, Dr Reddy’s approved for emergency use
Published
DCGI V.G. Somani. Source: PIB/YouTube New Delhi: The Drugs Controller General of India (DCGI) has approved an anti-COVID-19 oral drug,...
Full ArticlePublished
DCGI V.G. Somani. Source: PIB/YouTube New Delhi: The Drugs Controller General of India (DCGI) has approved an anti-COVID-19 oral drug,...
Full ArticleDeveloped by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic..
According to ministry, it accumulates in the infected cells and prevents virus growth.